The impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusions

Respiration

Volumn 85, Issue 1, 2012, Pages 36-42

  Sabur, Natasha F ^a   Chee, Alex ^a   Stather, David R ^a   MacEachern, Paul ^a   Amjadi, Kayvan ^b   Hergott, Christopher A ^c   Dumoulin, Elaine ^d   Gonzalez, Anne V ^e   Tremblay, Alain ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Malignant pleural effusion; Palliative care; Pleural catheter; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CATHETER; COHORT ANALYSIS; COUGHING; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INDWELLING CATHETER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURAL EFFUSION; PALLIATIVE THERAPY; PLEURA EFFUSION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SOCIAL STATUS; THORACOCENTESIS; THORAX PAIN; TUNNELED PLEURAL CATHETER;

ADULT; AGED; AGED, 80 AND OVER; CATHETERS; DRAINAGE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUEBEC; SURVIVAL RATE;

EID: 84871714876     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000342343     Document Type: Article

References (37)

1. Sahn SA: Malignancy metastatic to the pleura. Clin Chest Med 1998; 19: 351-361 (Pubitemid 28277882)
2. Chernow B, Sahn SA: Carcinomatous involvement of the pleura: An analysis of 96 patients. Am J Med 1977; 63: 695-702 (Pubitemid 8222934)
3. Heffner JE, Nietert PJ, Barbieri C: Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000; 117: 79-86 (Pubitemid 30053624)
4. Pilling JE, Dusmet ME, Ladas G, Goldstraw P: Prognostic factors for survival after surgical palliation of malignant pleural effusion. J Thorac Oncol 2010; 5: 1544-1550
5. Rodriguez-Panadero F, Montes-Worboys A: Mechanisms of pleurodesis. Respiration 2012; 83: 91-98
6. Lee YC, Baumann MH, Maskell NA, Waterer GW, Eaton TE, Davies RJ, et al: Pleurodesis practice for malignant pleural effusions in five English-speaking countries: Survey of pulmonologists. Chest 2003; 124: 2229-2238 (Pubitemid 38010594)
7. Rehse DH, Aye RW, Florence MG: Respiratory failure following talc pleurodesis. Am J Surg 1999; 177: 437-440 (Pubitemid 29252818)
8. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al: Safety of pleurodesis with talc poudrage in malignant pleural effusion: A prospective cohort study. Lancet 2007; 369: 1535-1539 (Pubitemid 46670303)
9. Aelony Y, Yao JF: Prolonged survival after talc poudrage for malignant pleural mesothelioma: Case series. Respirology 2005; 10: 649-655 (Pubitemid 44944463)
10. Diacon AH, Wyser C, Bolliger CT, Tamm M, Pless M, Perruchoud AP, et al: Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med 2000; 162: 1445-1449
11. Arapis K, Caliandro R, Stern JB, Girard P, Debrosse D, Gossot D: Thoracoscopic palliative treatment of malignant pleural effusions: Results in 273 patients. Surg Endosc 2006; 20: 919-923 (Pubitemid 43825198)
12. Putnam JB Jr., Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, et al: A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86: 1992-1999
13. Tremblay A, Michaud G: Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006; 129: 362-368 (Pubitemid 43289856)
14. Van Meter ME, McKee KY, Kohlwes RJ: Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: A systematic review. J Gen Intern Med 2011; 26: 70-76
15. Efthymiou CA, Masudi T, Thorpe JAC, Papagiannopoulos K: Malignant pleural effusion in the presence of trapped lung: Fiveyear experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg 2009; 9: 961-964
16. Ohm C, Park D, Vogen M, Bendick P, Welsh R, Pursel S, et al: Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions. Am Surg 2003; 69: 198-202
17. Pien GW, Gant MJ, Washam CL, Sterman DH: Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001; 119: 1641-1646 (Pubitemid 32744916)
18. Qureshi RA, Collinson SL, Powell RJ, Froeschle PO, Berrisford RG: Management of malignant pleural effusion associated with trapped lung syndrome. Asian Cardiovasc Thorac Ann 2008; 16: 120-123 (Pubitemid 351649798)
19. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, Group BTSPDG: Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65(suppl 2):ii32-ii40
20. MacEachern P, Stather D, Tremblay A: Tunelled pleural catheters; in Beamis JF Mathur P, Mehta AC (eds): Interventional Pulmonary Medicine, ed 2. New York, Informa Healthcare, 2009
21. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-oflife instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376 (Pubitemid 23073154)
22. Fayers PM Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group: The EORTC QLQ-C30 Scoring Manual (ed 3). Brussels, European Organisation for Research and Treatment of Cancer, 2001
23. Osoba D, Rodrigues G, Myles J, Zee B, Pater J: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-144 (Pubitemid 28041591)
24. van den Toorn LM, Schaap E, Surmont VFM, Pouw EM, van der Rijt KCD, van Klaveren RJ: Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer 2005; 50: 123- 127 (Pubitemid 41297479)
25. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778 (Pubitemid 17142007)
26. Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, et al: Effect of an indwelling pleural catheter vs. chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized controlled trial. JAMA 2012; 307: 1-7
27. Groenvold M, Klee MC, Sprangers MA, Aaronson NK: Validation of the EORTC QLQC30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50: 441-450 (Pubitemid 27223274)
28. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S: Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995; 13: 1249-1254
29. Mauer ME, Taphoorn MJ, Bottomley A, Coens C, Efficace F, Sanson M, et al: Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol 2007; 25: 5731-5737
30. Braun DP, Gupta D, Staren ED: Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer 2011; 11: 353
31. Hoyer M, Johansson B, Nordin K, Bergkvist L, Ahlgren J, Lidin-Lindqvist A, et al: Healthrelated quality of life among women with breast cancer - a population-based study. Acta Oncol 2011; 50: 1015-1026
32. Caissie A, Culleton S, Nguyen J, Zhang L, Zeng L, Holden L, et al: EORTC QLQ-C15- PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support Care Cancer 2012; 20: 841- 848
33. Schniewind B, Rose T, Woltmann N, Walter J, Becker T, Dohrmann P, et al: Clinical outcomes and health-related quality of life after thoracoscopic talc pleurodesis. J Palliat Med 2012; 15: 37-42
34. Pijls-Johannesma M, Houben R, Boersma L, Grutters J, Seghers K, Lambin P, et al: Highdose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiother Oncol 2009; 91: 443-448
35. Bang SM, Park SH, Kang HG, Jue JI, Cho IH, Yun YH, et al: Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 2005; 13: 515-521
36. Oviatt PL, Stather DR, Michaud G, MacEachern P, Tremblay A: Exercise capacity, lung function, and quality of life after interventional bronchoscopy. J Thorac Oncol 2011; 6: 38-42
37. Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, et al: The development of the EORTC QLQ-C15- PAL: A shortened questionnaire for cancer patients in palliative care. Eur J Cancer 2006; 42: 55-64 (Pubitemid 41818953)